Inventor
SCHMITT THOMAS M
US17 patents
⚠️ This page may combine multiple inventors who share the name “SCHMITT THOMAS M”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
FRED HUTCHINSON CANCER CENTER
8 patentsUS11725210B2Aug 15, 2023
Immunomodulatory fusion proteins and uses thereof
FRED HUTCHINSON CANCER CENTER4 citations71
US12448430B2Oct 21, 2025
High avidity WT1 T cell receptors and uses thereof
FRED HUTCHINSON CANCER CENTER0 citations59
US12365906B2Jul 22, 2025
Immunomodulatory fusion proteins and uses thereof
FRED HUTCHINSON CANCER CENTER0 citations59
US12012443B2Jun 18, 2024
Immunomodulatory fusion proteins and uses thereof
FRED HUTCHINSON CANCER CENTER1 citations59
US11458191B2Oct 4, 2022
Binding proteins specific for RAS neoantigens and uses thereof
FRED HUTCHINSON CANCER CENTER1 citations55
US11382954B2Jul 12, 2022
Binding proteins specific for RAS neoantigens and uses thereof
FRED HUTCHINSON CANCER CENTER1 citations55
US12595290B2Apr 7, 2026
T cell receptors specific for mesothelin and their use in immunotherapy
FRED HUTCHINSON CANCER CENTER0 citations49
US11534461B2Dec 27, 2022
High affinity merkel cell polyomavirus T antigen-specific TCRS and uses thereof
FRED HUTCHINSON CANCER CENTER0 citations48
HUTCHINSON FRED CANCER RES
4 patentsUS10538572B2Jan 21, 2020
T cell immunotherapy specific for WT-1
HUTCHINSON FRED CANCER RES5 citations72
US11026969B2Jun 8, 2021
High affinity T cell receptors and uses thereof
HUTCHINSON FRED CANCER RES1 citations60
US10875904B2Dec 29, 2020
Enhanced affinity T cell receptors and methods for making the same
HUTCHINSON FRED CANCER RES0 citations51
US9751928B2Sep 5, 2017
Enhanced affinity T cell receptors and methods for making the same
HUTCHINSON FRED CANCER RES0 citations51